The document is about the challenges currently facing the Indian pharmaceutical industry. It discusses how the industry has long played a critical role in making life-saving drugs accessible worldwide but is now experiencing its worst slowdown. It examines whether the factors causing this are the same structural issues that had previously threatened the industry, or problems of the industry's own making. The article aims to determine if the current impediments are reversible. Interviews with industry experts and policymakers provide insights into the regulatory hurdles, export market challenges, and other issues impacting the pharmaceutical sector.

1. FOREIGN TRADE . EXPORTS . IMPORTS
www.thedollarbusiness.com Vol.2 Issue 07 July 2015 100 $5
Instant Coffee
Brewing profits, instantly
This stimulator is helping Indian
exporters rake in big moolah
New Mangalore Port
The last mile question
What else can you expect from a
port which lacks connectivity?
Air Cargo
Flying in turbulent weather
Can India’s air cargo sector come
out of the slump?
THE INDIAN
PHARMACEUTICAL
INDUSTRY HAS LONG
BEEN A LIFE-SAVER
FOR MILLIONS, BUT IS
SUDDENLY IN NEED OF
A LIFE-GUARD
IN CHOPPY
WATERS?
LILIANNE PLOUMEN
Minister for Foreign Trade,
Government of the Netherlands
EBERHARD KERN
MD & CEO,
Mercedes-Benz India
HOWARD SKLAMBERG
Deputy Commissioner for Global
Regulatory Operations, USFDA
RAMESH SWAMINATHAN
Chief Financial Officer, Lupin Ltd.
DR. AMEDEO SCARPA
Trade Commissioner, ITA
DR. ARUN BHADRA THAPA
WHO Representative to India
...AND MORE!
EXCLUSIVE INSIDE

2. 6 THE DOLLAR BUSINESS II APRIL 2015
INDIA TRADE
THIS MONTH
Foreign tourist-led boom, Maggi’s doom, pulses exports zoom while
imports of American chickens loom and a lot more
MONOLOGUE
PEOPLE SPEAK
Important policymakers’ reactions to some of the biggest events that are
shaping the world of trade & commerce
GLOBAL TRADE
THIS MONTH
From the downtrend in Pakistan-Sri Lanka trade and surging British gin
exports to Zimbabwe’s rhino exports and much more
Volume: 2 Issue: 07 July 2015
www.thedollarbusiness.com
facebook.com/tdbIndia
twitter.com/TheDollarBiz
in.linkedin.com/in/thedollarbusiness/
COVER STORY – INDIAN PHARMA34
20
12
10
The Indian pharmaceutical industry, which has played a critical
role in making life-saving drugs accessible to the poorest of the
poor, is currently going through its worst slowdown. What has
caused this? Are they the same factors that had almost derailed
it a decade back? Or is it something of its own doing? More
importantly, is it curable?
IN URGENT
NEED OF A
CURE
President (VMPL) : Steven Philip Warner
&Editor-in-Chief
EDITORIAL & RESEARCH
Editor : Manish K. Pandey
Executive Editor : Shakti Shankar Patra
Senior Editor : Satyapal Menon
Senior Assistant Editors : Sisir Kumar Pradhan
Shivani (Vig) Kapoor
Assistant Editor : Neha Dewan
Principal Correspondent : Vanita Peter D'souza
Correspondent :AadhiraAnandh M.
Editorial Coordinator : Deepa Pandey
EDITORIAL CONSULTING BOARD
Founder & Editor :Anil Goyal
Publisher :Avnish Goyal
Chief Consulting Editor : Dr.A. K. Sengupta (Former Dean, IIFT)
Editorial Advisors : Dr. N.K. Goyal (CMAI)
:Atul Kumar Saxena (IIA)
BRAND ACTIVATION & RESPONSE
Vice-President :Aninda Mondal
Senior Manager : Saroj Roy
Deputy Manager (Alliances) : Swati Sinha
INTERNATIONAL REPRESENTATIVES
Seoul(SouthKorea) : Justin Yoon (+82-2-6241-4256)
London(UK) : S. Puri (+44 207 376 1996)
ART & PHOTOGRAPHY
Art Director : Sujesh Kumar G.
Senior Designers : Sanat Singh, Sonia Kholgade
Designer : Gopal Ganesh Reddy
Photographer : Dileep Kumar
THE DOLLAR BUSINESS ONLINE
Deputy Editor : Jayarama Emani
Senior Editor : Himanshu Vatsa
Assistant Editor : D. Sai Nikesh
Web Developer : K. Naveen
SEO Specialist :Alimoddin Mohd.
Associate (Web & Network) : C. Dileep Reddy
CIRCULATION & DISTRIBUTION
General Manager : S. S. Sudesh
Assistant Manager : Sanjeev Jain, Buddhi Sagar Pandey
Senior Executive : K. Chandra Prakash
SUBSCRIPTIONS
Manager : M. Vinay Kumar
FINANCE & LOGISTICS
Manager : Parchuri Jhansi
Associate : Raj Jarikote
PRINTER
Kala Jyothi Process Pvt. Ltd.,
1-1-60/5, RTC Cross Road, Musheerabad, Hyderabad,Telangana 500020, IN
PUBLISHED AT
5-2-198/4, Distillery Road, Ranigunj, Secunderabad,
Telangana 500003, IN
FOR EDITORIAL/CONTENT
Email: editorial@thedollarbusiness.com . Tel: +91-40-6677 0766
FOR ADVERTISEMENT
Email: ads@thedollarbusiness.com . Tel: +91-40-6677 0765
FOR SUBSCRIPTION
Email: subscription@thedollarbusiness.com . 18001030385 (Toll free)
For queries / comments you can send us an SMS at +91-888-633-1947
© Copyright 2014
No part of this magazine may be reproduced in whole or in part without an ex-
pressed permission of the publisher. The information on this magazine is for infor-
mation purpose only.The Editor is responsible for the selection of news and content
under PRB Act. Vimbri Media Pvt. Ltd. assumes no liability or responsibility for any
inaccurate, delayed or incomplete information, or for any actions taken in reliance
thereon.The information contained about each individual, event or organisation has
been provided by such individual, event organisers or organisation without verifica-
tion by us.All disputes are subject to exclusive jurisdiction of competent courts and
forums in Hyderabad, Telangana.
Printed and published by Avnish Goyal for Vimbri Media Pvt. Ltd. Published at
5-2-198/4, Distillery Road, Ranigunj, Secunderabad - 500 003, Telangana.
Printedat:KalaJyothiProcessPvt.Ltd.,1-1-60/5,RTCCrossRoads,Musheerabad,
Hyderabad - 500 020, Telangana.

3. APRIL 2015 II THE DOLLAR BUSINESS 7
LILIANNE PLOUMEN
Satisfied with the outcomes of her trip to India,
the Dutch trade minister says stagnancy in
India-Netherlands trade is just temporary
96
H. SKLAMBERG
The senior USFDA official
tells us that this agency
doesn’t discriminate against
Indian pharma companies
AMEDEO SCARPA
Italian Trade Agency’s Trade
Commissioner to India tells
us everything there is to
know about India-Italy trade
EBERHARD KERN
In a candid interview, the MD
& CEO of Mercedes-Benz
reveals how he reclaimed lost
glory for his company
R. SWAMINATHAN
The CFO of Lupin Ltd.
speaks about regulatory and
other challenges his company
faces in its export markets
54
26 30
52
SPOTLIGHT
NEPAL
While Mt. Everest’s lure brings
the entire world to it, in trade, it’s
nothing like the Everest
THE MIDAS TOUCH
BALL POINT PEN
Yet another example of Indian
exporters penning their own
success stories, quite literally
SECRET INGREDIENT
INSTANT COFFEE
How Indian exporters have found a
way around the domination of big
brands while brewing instant profits
POLICY FOCUS
SEIS
While the much needed equaliser
is here, why are Indian services
exports continuing to trend down?
DOCKYARD
NEW MANGALORE PORT
This major port is suffering from
hypoxia because the arteries are in
bad shape
PRIME FOCUS
AIR CARGO IN INDIA
Can India’s air cargo sector come
out of the slump?
24
72 90
9282
56
60
68
TDB FORUM
ASK A QUESTION
Questions about foreign trade that
hit our mail box in June and of
course, their answers
DATEBOOK
Some trade shows and fairs you
shouldn’t miss out on in India and
abroad in July and August

4. 34 THE DOLLAR BUSINESS II JULY 2015
COVER STORY TROUBLE WITH INDIAN PHARMA

5. JULY 2015 II THE DOLLAR BUSINESS 35
BY NEHA DEWAN & SHAKTI SHANKAR PATRA
For over four decades, the Indian pharmaceutical industry has played a critical
role in making life-saving drugs accessible to the poorest of the poor, not only in
the developing and the least-developed, but also in the developed world. Every
time it has faced any serious crisis, the entire world has prayed for and worked
towards lending it a helping hand. However, lately, it is going through its worst
slowdown. What factors have caused this? Are they the same structural factors
that had almost derailed the sector a decade back? Or is it something of its own
doing? More importantly, are these impediments reversible?
HAS
INDIAN
PHARMA
LOST ITS
PATH?